Generated by AI
Adlai Nortye Group Ltd. American Depositary Shares is the U.S.-traded share class of Adlai Nortye Ltd., a clinical-stage biotechnology company focused on developing cancer therapies. The company’s current work centers on advancing oncology drug candidates through clinical research, with programs spanning targeted treatments designed to address different tumor types and treatment settings. Its portfolio includes investigational therapies aimed at modulating key cancer pathways and the tumor microenvironment, reflecting a focus on precision medicine approaches in oncology. Adlai Nortye serves as a small but active participant in the global biopharmaceutical market, with operations connected to drug discovery, preclinical development, and late-stage clinical testing. The American Depositary Shares give U.S. investors access to the company’s ordinary shares through a structure commonly used by international life sciences firms.
Website77 Robinson Road
Singapore, NJ, 068896
Singapore
The latest articles about ANL.
Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.
Summary of Apr 16's posts. Generated by AI.
Summary of Feb 3's posts. Generated by AI.
Summary of Feb 3's posts. Generated by AI.
No summary yet.
Summary of Apr 16's posts. Generated by AI.
Investors talking about ANL also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.